These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11501194)

  • 21. Management of nonalcoholic fatty liver disease: a 60-year-old man with probable nonalcoholic fatty liver disease: weight reduction, liver biopsy, or both?
    Afdhal NH
    JAMA; 2012 Aug; 308(6):608-16. PubMed ID: 22760235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-alcoholic steatohepatitis.
    Das K; Kar P
    J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
    Reha JL; Lee S; Hofmann LJ
    Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Non alcoholic steatohepatitis: an emergent and potentially serious pathology].
    Elloumi H; Arfaoui D; Joudène M; Sriha B; Korbi M; Ajmi S
    Tunis Med; 2004 Jun; 82(6):484-91. PubMed ID: 15517946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nonalcoholic fatty liver disease.
    Grant LM; Lisker-Melman M
    Ann Hepatol; 2004; 3(3):93-9. PubMed ID: 15505593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Non-alcoholic liver disease (NASH)].
    Maier KP
    Praxis (Bern 1994); 2006 Aug; 95(34):1267-9. PubMed ID: 16956020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.
    Ludwig J; Viggiano TR; McGill DB; Oh BJ
    Mayo Clin Proc; 1980 Jul; 55(7):434-8. PubMed ID: 7382552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Etiopathogenesis of nonalcoholic steatohepatitis.
    Chitturi S; Farrell GC
    Semin Liver Dis; 2001; 21(1):27-41. PubMed ID: 11296694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic criteria for non-alcoholic steatohepatitis].
    Hashimoto E
    Nihon Rinsho; 2006 Jun; 64(6):1025-32. PubMed ID: 16768105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utility of the ELF Test for Detecting Steatohepatitis in Morbid Obese Patients with Suspicion of Nonalcoholic Fatty Liver Disease.
    López IC; Aroca FG; Bernal MDF; Mompeán JAL; Bernal ÁB; Martínez AMH; Barba EM; Velasco JAN; Paricio PP
    Obes Surg; 2017 Sep; 27(9):2347-2353. PubMed ID: 28229316
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Update on nonalcoholic fatty liver disease.
    McCullough AJ
    J Clin Gastroenterol; 2002 Mar; 34(3):255-62. PubMed ID: 11873108
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma with nonalcoholic steatohepatitis.
    Mori S; Yamasaki T; Sakaida I; Takami T; Sakaguchi E; Kimura T; Kurokawa F; Maeyama S; Okita K
    J Gastroenterol; 2004; 39(4):391-6. PubMed ID: 15168253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.
    McCullough AJ
    Clin Liver Dis; 2004 Aug; 8(3):521-33, viii. PubMed ID: 15331061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cases from the spectrum of nonalcoholic steatohepatitis.
    Abdelmalek M; Ludwig J; Lindor KD
    J Clin Gastroenterol; 1995 Mar; 20(2):127-30. PubMed ID: 7769192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease.
    Abrams GA; Kunde SS; Lazenby AJ; Clements RH
    Hepatology; 2004 Aug; 40(2):475-83. PubMed ID: 15368453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-alcoholic steatohepatitis: what is it, and why is it important in the Asia-Pacific region?
    Farrell GC
    J Gastroenterol Hepatol; 2003 Feb; 18(2):124-38. PubMed ID: 12542595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of non-alcoholic fatty liver disease].
    Koek GH
    Ned Tijdschr Geneeskd; 2011; 155():A3181. PubMed ID: 21649947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.